KisoJi Biotechnology
PrivateLast Round
Series B
Dec 2, 2024
Total Funding Raised
$82M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
KisoJi Biotechnology is a biotechnology company that develops multi-specific antibody therapeutics for oncology and inflammatory diseases using a proprietary AI-enabled discovery platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Medical AI, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
KisoJi Biotechnology Comparables
Compare KisoJi Biotechnology with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| BigHat Biosciences | 82% | |
| Alloy Therapeutics | 81% | |
| Leveragen, Inc. | 80% |
KisoJi Biotechnology Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Dec 2, 2024 | ||||
| Series B | Oct 1, 2024 |
KisoJi Biotechnology Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Investissement Québec | Series B |
| Fonds de solidarité FTQ | Series B |
| Remiges Ventures | Series A Extension, Series B |
| BDC Capital | Series A Extension |
| Lumira Ventures | Series B |
| adMare BioInnovations | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 29, 2026
Grew 31% QoQ, from 16 to 21 employees.
- Aug 10, 2026
Open roles increased to 14, representing 88% of headcount.
Recent news
Latest coverage and updates
- launchesAug 17, 2026
KisoJi Biotechnology Inc. launched Phase I/IIa clinical trial for people with selected TROP2-expressing solid tumours on Aug 17th '26.
- is_developingAug 14, 2026
KisoJi Biotechnology Inc. is developing KJ-103.
KisoJi Biotechnology Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about KisoJi Biotechnology's valuation, stock price, and market status.
Is KisoJi Biotechnology a public or private company?
KisoJi Biotechnology is a private company.
What is the current stock price of KisoJi Biotechnology?
KisoJi Biotechnology is a private company with no public stock price. No recent secondary market data is available.
How much is KisoJi Biotechnology worth (valuation)?
Valuation information for KisoJi Biotechnology is not publicly available.
Can I buy KisoJi Biotechnology stock?
KisoJi Biotechnology shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was KisoJi Biotechnology's last funding round?
KisoJi Biotechnology's most recent funding round was Series B on October 1, 2024.
Who are the main investors in KisoJi Biotechnology?
Key investors in KisoJi Biotechnology include Investissement Québec, Lumira Ventures.
Will KisoJi Biotechnology IPO soon?
No public IPO plans have been announced for KisoJi Biotechnology.
How can I track KisoJi Biotechnology secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor KisoJi Biotechnology's secondary market activity and sign up for updates.